Increasing resilience of medical supply chains during the COVID-19 pandemic
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
Innovation can provide swift remedies to the COVID-19 linked recession. Policy should contain incentives to innovate in the long-term.
COVID-19 stimulus packages must carry energy efficiency incentives to help industries and economies rebound.